AT446085T - Particles for use in a pharmaceutical composition - Google Patents

Particles for use in a pharmaceutical composition

Info

Publication number
AT446085T
AT446085T AT01998327T AT01998327T AT446085T AT 446085 T AT446085 T AT 446085T AT 01998327 T AT01998327 T AT 01998327T AT 01998327 T AT01998327 T AT 01998327T AT 446085 T AT446085 T AT 446085T
Authority
AT
Austria
Prior art keywords
particles
use
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
AT01998327T
Other languages
German (de)
Inventor
John Staniforth
David Morton
Original Assignee
Vectura Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to GB0029261A priority Critical patent/GB0029261D0/en
Priority to GB0030946A priority patent/GB0030946D0/en
Priority to GB0124009A priority patent/GB0124009D0/en
Application filed by Vectura Ltd filed Critical Vectura Ltd
Priority to PCT/GB2001/005305 priority patent/WO2002043700A2/en
Publication of AT446085T publication Critical patent/AT446085T/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27255994&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AT446085(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
AT01998327T 2000-11-30 2001-11-30 Particles for use in a pharmaceutical composition AT446085T (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB0029261A GB0029261D0 (en) 2000-11-30 2000-11-30 Method of making particles for use in a pharmaceutical composition
GB0030946A GB0030946D0 (en) 2000-12-19 2000-12-19 Method of making particles for use in a pharmaceutical composition
GB0124009A GB0124009D0 (en) 2001-10-05 2001-10-05 Particles for use in a pharmaceutical composition
PCT/GB2001/005305 WO2002043700A2 (en) 2000-11-30 2001-11-30 Particles for use in a pharmaceutical composition

Publications (1)

Publication Number Publication Date
AT446085T true AT446085T (en) 2009-11-15

Family

ID=27255994

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01998327T AT446085T (en) 2000-11-30 2001-11-30 Particles for use in a pharmaceutical composition

Country Status (8)

Country Link
US (3) US8580306B2 (en)
EP (3) EP2292212A3 (en)
AT (1) AT446085T (en)
AU (1) AU2085702A (en)
DE (1) DE60140268D1 (en)
ES (2) ES2689704T3 (en)
PT (1) PT1337239E (en)
WO (1) WO2002043700A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9515182D0 (en) * 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
AU2211802A (en) 2000-11-30 2002-06-11 Vectura Ltd Pharmaceutical compositions for inhalation
EP2283817B1 (en) 2000-11-30 2016-05-18 Vectura Limited Method of making particles for use in a pharmaceutical composition
GB0009469D0 (en) * 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
AT378039T (en) * 2000-06-27 2007-11-15 Vectura Ltd Production method of particles for use in a pharmaceutical composition
AT446085T (en) * 2000-11-30 2009-11-15 Vectura Ltd Particles for use in a pharmaceutical composition
US20040121003A1 (en) * 2002-12-19 2004-06-24 Acusphere, Inc. Methods for making pharmaceutical formulations comprising deagglomerated microparticles
US20120321717A1 (en) * 2003-04-14 2012-12-20 Vectura Ltd. Devices and pharmaceutical compositions for enhancing dosing efficiency
US20060147389A1 (en) * 2004-04-14 2006-07-06 Vectura Ltd. Devices and pharmaceutical compositions for enhancing dosing efficiency
GB0327723D0 (en) 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
GB0321607D0 (en) * 2003-09-15 2003-10-15 Vectura Ltd Manufacture of pharmaceutical compositions
GB0425758D0 (en) * 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
GB0426301D0 (en) * 2004-11-30 2004-12-29 Vectura Ltd Pharmaceutical formulations
WO2007070843A2 (en) * 2005-12-15 2007-06-21 Acusphere, Inc. Processes for making particle-based pharmaceutical formulations for oral administration
US9072664B2 (en) 2008-05-22 2015-07-07 3M Innovative Properties Company Process for manufacturing flowable powder drug compositions
EP2309978B1 (en) 2008-06-26 2018-12-26 3M Innovative Properties Company Dry powder pharmaceutical compositions for pulmonary administration, and methods of manufacturing thereof
US9861580B2 (en) 2008-07-02 2018-01-09 3M Innovative Properties Company Method of making a dry powder pharmaceutical composition
KR20120104235A (en) * 2009-12-14 2012-09-20 키에시 파르마슈티시 엣스. 피. 에이. Antibiotic microparticles for inhalation
CN104470503A (en) 2012-04-13 2015-03-25 葛兰素史克知识产权开发有限公司 Aggregate particles
JP5087182B1 (en) * 2012-06-13 2012-11-28 クリニプロ株式会社 Manufacturing method for inhalation powder
WO2019070693A1 (en) * 2017-10-02 2019-04-11 Board Of Regents, The University Of Texas System Inhalable composition of clofazimine and methods of use

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB124009A (en) 1918-01-12 1919-03-12 Walter Edward Kimber Improvements in and connected with the Manufacture of Tools for Turning, Planing, Boring and similar purposes.
GB1381872A (en) 1971-06-22 1975-01-29 Fisons Ltd Pharmaceutical compositions for inhalation
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
IT1204826B (en) 1986-03-04 1989-03-10 Chiesi Farma Spa Pharmaceutical compositions for inhalation
US5320906A (en) * 1986-12-15 1994-06-14 Vestar, Inc. Delivery vehicles with amphiphile-associated active ingredient
AT77947T (en) * 1987-04-09 1992-07-15 Fisons Plc Pentamidine pharmaceutical compositions containing them.
JP2668880B2 (en) 1987-06-23 1997-10-27 日本油脂株式会社 Manufacturing method for coating amino acids
US5190764A (en) 1988-03-03 1993-03-02 Hokko Chemical Industry Co., Ltd. Agent for imparting a sustained release property to a pesticide, a pesticide having a sustained release property and a process for the production thereof
US5223244A (en) 1988-06-20 1993-06-29 Shiseido Company, Ltd. Aerosol composition
US4906476A (en) * 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
WO1990013327A1 (en) * 1989-04-28 1990-11-15 Riker Laboratories, Inc. Dry powder inhalation device
US5188837A (en) * 1989-11-13 1993-02-23 Nova Pharmaceutical Corporation Lipsopheres for controlled delivery of substances
GB9024366D0 (en) 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5413804A (en) * 1991-04-23 1995-05-09 Cacique, Inc. Process for making whey-derived fat substitute product and products thereof
GB2269992A (en) * 1992-08-14 1994-03-02 Rh Ne Poulenc Rorer Limited Powder inhalation formulations
JPH0696517A (en) 1992-09-11 1994-04-08 Matsushita Electric Ind Co Ltd Magnetic disk apparatus
AU660852B2 (en) * 1992-11-25 1995-07-06 Elan Pharma International Limited Method of grinding pharmaceutical substances
US5506203C1 (en) * 1993-06-24 2001-02-06 Astra Ab Systemic administration of a therapeutic preparation
TW402506B (en) 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
DE4323636A1 (en) * 1993-07-15 1995-01-19 Hoechst Ag Drug preparations of coated, heavy water-soluble drugs for inhalation dosage forms and methods for their preparation
US5744155A (en) * 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
CZ295827B6 (en) * 1994-03-07 2005-11-16 Nektar Therapeutics Method for aerosolizing a dose of insulin, insulin composition and use thereof
US5711934A (en) * 1994-04-11 1998-01-27 Abbott Laboratories Process for the continuous milling of aerosol pharmaceutical formulations in aerosol propellants
US6103271A (en) * 1994-12-02 2000-08-15 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Microencapsulation and electrostatic processing method
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
MY131733A (en) 1994-12-22 2007-08-30 Astra Ab Aerosol drug formulations
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US5612053A (en) * 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
US5635160A (en) * 1995-06-07 1997-06-03 The University Of North Carolina At Chapel Hill Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions
US5931809A (en) * 1995-07-14 1999-08-03 Depotech Corporation Epidural administration of therapeutic compounds with sustained rate of release
GB9515182D0 (en) * 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
DE19645359A1 (en) * 1996-11-04 1998-05-07 Bayer Ag A process for preparing alkylhalosilanes
ES2189269T3 (en) * 1997-12-03 2003-07-01 Britannia Pharmaceuticals Ltd Improvements in drugs for the treatment of asthma.
US6178414B1 (en) * 1997-12-16 2001-01-23 Nortel Networks Limited Method and apparatus for updating and searching an ordered list of values stored within a memory resource
US6086376A (en) 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
US7521068B2 (en) * 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
PL200941B1 (en) 1998-11-13 2009-02-27 Jagotec Ag Dry powder for inhalation
US6984404B1 (en) 1998-11-18 2006-01-10 University Of Florida Research Foundation, Inc. Methods for preparing coated drug particles and pharmaceutical formulations thereof
CN1200693C (en) 1998-11-18 2005-05-11 佛罗里达大学 Method for preparing coated drug particles and pharmaceutical formulations
GB9826783D0 (en) 1998-12-04 1999-01-27 Scherer Ltd R P Inhalation powders
GB9827145D0 (en) * 1998-12-09 1999-02-03 Co Ordinated Drug Dev Improvements in or relating to powders
US6542490B1 (en) * 1999-01-29 2003-04-01 Nortel Networks Limited Data link control proctocol for 3G wireless system
IT1309592B1 (en) 1999-03-05 2002-01-24 Chiesi Farma Spa Particles vehicle modified to be used in the pharmaceutical preparation in the form of polymers diformulazioni by inhalation and
AT363892T (en) 1999-03-05 2007-06-15 Chiesi Farma Spa Improved powder formulations for inhalation
US7090831B1 (en) * 1999-04-14 2006-08-15 Smithkline Beecham Corporation Pharmaceutical aerosol formulation
US6406745B1 (en) 1999-06-07 2002-06-18 Nanosphere, Inc. Methods for coating particles and particles produced thereby
ITMI991582A1 (en) 1999-07-16 2001-01-16 Chiesi Farma Spa Powder consisting of particles having a perfectly smooth surface to be used as vehicles for the preparation of mixtures inhales
US6197369B1 (en) * 1999-09-30 2001-03-06 New Jersey Institute Of Technology Method of particle coating
EP2283817B1 (en) * 2000-11-30 2016-05-18 Vectura Limited Method of making particles for use in a pharmaceutical composition
GB0008660D0 (en) 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
GB0009469D0 (en) * 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
AT378039T (en) * 2000-06-27 2007-11-15 Vectura Ltd Production method of particles for use in a pharmaceutical composition
GB0009468D0 (en) * 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formulations for use in inhaler devices
PE12272001A1 (en) * 2000-04-17 2002-01-07 Chiesi Farma Spa Pharmaceutical formulations for DPIs in the form of hard agglomerates
US6404772B1 (en) * 2000-07-27 2002-06-11 Symbol Technologies, Inc. Voice and data wireless communications network and method
AU2002211311B2 (en) 2000-10-09 2006-08-31 3M Innovative Properties Company Medicinal aerosol formulations
GEP20063865B (en) 2000-10-12 2006-07-10 Boehringer Ingelheim Pharma Novel tiotropium-containing inhalation powder
AT446085T (en) * 2000-11-30 2009-11-15 Vectura Ltd Particles for use in a pharmaceutical composition
GB0124009D0 (en) 2001-10-05 2001-11-28 Vectura Ltd Particles for use in a pharmaceutical composition
US20060147389A1 (en) 2004-04-14 2006-07-06 Vectura Ltd. Devices and pharmaceutical compositions for enhancing dosing efficiency
GB0321607D0 (en) 2003-09-15 2003-10-15 Vectura Ltd Manufacture of pharmaceutical compositions
WO2005025535A2 (en) 2003-09-15 2005-03-24 Vectura Limited Methods for preparing pharmaceutical compositions

Also Published As

Publication number Publication date
EP2168571A3 (en) 2011-11-16
EP2292212A2 (en) 2011-03-09
US20040071635A1 (en) 2004-04-15
WO2002043700A2 (en) 2002-06-06
EP2168571A2 (en) 2010-03-31
EP2168571B1 (en) 2018-08-22
US10238601B2 (en) 2019-03-26
US20170216202A1 (en) 2017-08-03
EP1337239A2 (en) 2003-08-27
EP1337239B1 (en) 2009-10-21
EP2292212A3 (en) 2012-08-08
AU2085702A (en) 2002-06-11
ES2334642T5 (en) 2016-03-07
US9585839B2 (en) 2017-03-07
EP1337239B2 (en) 2015-11-25
US8580306B2 (en) 2013-11-12
PT1337239E (en) 2010-01-26
ES2334642T3 (en) 2010-03-15
WO2002043700A3 (en) 2002-10-24
ES2689704T3 (en) 2018-11-15
DE60140268D1 (en) 2009-12-03
US20140037737A1 (en) 2014-02-06

Similar Documents

Publication Publication Date Title
DE60022785D1 (en) modular bandage
DE69936002D1 (en) Adapted spoon for oral drug delivery
DE60137039D1 (en) diapers displacement of closures for the preparation of
DE60115111D1 (en) Device for Ödemstandmessung
EE04915B1 (en) Kinuklidiinderivaadid, process for preparing them, intermediate compounds, their use in the pharmaceutical composition, and
DE60129998D1 (en) Device for implantation in bone
DE60129994D1 (en) envelope device for a prosthetic aufblasregelung
DE50108408D1 (en) System for blood
DE60138132D1 (en) A process for the simultaneous coproduction and reinopylester
AT368388T (en) Insoluble protein particles
EE200200487A (en) The azetidine derivatives, processes for their preparation and pharmaceutical composition,
AT269732T (en) Fog chamber for use in a device-dose inhalation
AT313312T (en) dental materials
DE59913400D1 (en) 3D camera for detecting surface structures, in particular for dental purposes
DE60038698D1 (en) Hydrogel-driven dosage form
DE60027590D1 (en) Aesthetic dental materials
NO20010156L (en) A catalyst composition and methods for its preparation and use in a polymeringsprosess
DE60014511D1 (en) Dental adhesive composition
DE60238934D1 (en) Node processors for use in paritätsprüfdecodern
AT306384T (en) Material system for use in 3D Print
DE60029819D1 (en) Information and control console for use in a netzgatawayschnittstelle
DE60013425D1 (en) Pharmaceutical compositions for aerosol formation and inhalation purposes
DE60144013D1 (en) Resin composition and use thereof
AT241391T (en) Battery-powered apparatus for delivering fragrance
AT424811T (en) milled particles

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1337239

Country of ref document: EP